£17.8M
Kheiron raises £17.8m Series A led by Atomico to expand clinical validation of its breast cancer AI software

Atomico led the Series A round with participation from Connect Ventures, Greycroft, Hoxton Ventures, and EXOR Seeds.
"The foundation of Kheiron’s approach to rigorous development and testing is to ensure reliably improved patient outcomes and safety by helping doctors in their daily practice,"
.png)